Sharplin, K.; Proudman, W.; Chhetri, R.; Tran, E.N.H.; Choong, J.; Kutyna, M.; Selby, P.; Sapio, A.; Friel, O.; Khanna, S.;
et al. A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data. Cancers 2023, 15, 4019.
https://doi.org/10.3390/cancers15164019
AMA Style
Sharplin K, Proudman W, Chhetri R, Tran ENH, Choong J, Kutyna M, Selby P, Sapio A, Friel O, Khanna S,
et al. A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data. Cancers. 2023; 15(16):4019.
https://doi.org/10.3390/cancers15164019
Chicago/Turabian Style
Sharplin, Kirsty, William Proudman, Rakchha Chhetri, Elizabeth Ngoc Hoa Tran, Jamie Choong, Monika Kutyna, Philip Selby, Aidan Sapio, Oisin Friel, Shreyas Khanna,
and et al. 2023. "A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data" Cancers 15, no. 16: 4019.
https://doi.org/10.3390/cancers15164019
APA Style
Sharplin, K., Proudman, W., Chhetri, R., Tran, E. N. H., Choong, J., Kutyna, M., Selby, P., Sapio, A., Friel, O., Khanna, S., Singhal, D., Damin, M., Ross, D., Yeung, D., Thomas, D., Kok, C. H., & Hiwase, D.
(2023). A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data. Cancers, 15(16), 4019.
https://doi.org/10.3390/cancers15164019
